Compounds > 9,10-dimethyl-1,2-benzanthracene
Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and rc 3095

9,10-dimethyl-1,2-benzanthracene has been researched along with rc 3095 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crean, DH; Liebow, C; Mang, TS; Penetrante, RB1
Kozacko, MF; Liebow, C; Mang, TS; Priore, RL; Schally, AV1

Other Studies

2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and rc 3095

ArticleYear
Evaluation of porfimer sodium fluorescence for measuring tissue transformation.
    Cancer, 1993, Nov-15, Volume: 72, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bombesin; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cheek; Cricetinae; Dihematoporphyrin Ether; Disease Models, Animal; Fluorescence; Mesocricetus; Mouth Neoplasms; Peptide Fragments; Photometry; Protein-Tyrosine Kinases; Somatostatin

1993
Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Bombesin; Cricetinae; Dihematoporphyrin Ether; Lasers; Mouth Neoplasms; Neoplasms, Radiation-Induced; Peptide Fragments; Precancerous Conditions; Time Factors

1996